To explore the clinical relevance of CDA in lung cancer, we analyzed CDA expression in lung adenocarcinomas using GEPIA35, a tool for analyzing the Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. This evidence concerns the gene CDA and lung carcinoma.